Answers are grounded in this paper and cite their sources.
The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) was chartered by the National Heart, Lung, and Blood Institute and the National Cancer Institute (NCI) in 2001 to conduct clinical trials aimed at improving the outcome of patients undergoing hematopoietic cell transplantation (HCT). Since its inception, activities of the BMT CTN have been guided by a series of State of the Science Symposia (SOSS), conducted to determine the most important and clinically relevant questions to be addressed by the cooperative activities of the Network.
No takes yet. Share an insight, caveat, or question.
Appelbaum et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: